INSIDE CHINA'S AI-NATIVE HOSPITALS:
A NEW ERA OF CANCER CARE DELIVERY
In China's most advanced centres, AI now supports doctors across the full cancer journey โ from imaging and molecular profiling to treatment planning, coordination and follow-up. Understand what is real and where the limits lie.
analyticsAt a Glance
- check_circleAI connected across imaging, pathology, genomics, clinical decision support and post-treatment follow-up.
- check_circleCan speed case review within a limited travel window โ particularly useful for international patients.
- check_circleSupports doctors โ AI never replaces clinical judgement or changes trial eligibility criteria.
- check_circleCentre selection matters more than the technology itself.
Where AI Is Being Used Across the Cancer Journey
An AI-native hospital is not simply one that uses one or two digital tools. It is a system where AI, large clinical datasets and digital platforms are connected across the care pathway. Every output must be interpreted by qualified specialists.
Cancer Imaging
Helps detect suspicious lesions on CT, MRI, mammography and PET-CT, supports nodule detection and risk scoring in lung cancer, and evaluates tumour burden or treatment response across modalities.
Digital Pathology
Whole-slide imaging and AI-assisted analysis support pathologists by highlighting tumour regions, quantifying biomarkers and improving consistency โ also enabling cross-border second opinions without shipping tissue blocks.
Genomics and Targeted Therapy
NGS with AI-assisted interpretation helps identify actionable mutations across lung (EGFR, ALK, MET), gastric (HER2, CLDN18.2, MSI-H), colorectal (RAS, BRAF, MSI-H) and many other settings.
Trial Matching and Follow-Up
AI-based matching screens records against complex trial eligibility criteria and shortens the search. Digital follow-up platforms help patients report symptoms and flag high-risk problems for earlier review after returning home.
What AI Does and Does Not Do
Used responsibly and supervised by experienced doctors, AI can speed case review and support multidisciplinary planning. But technology does not change eligibility, and centre selection matters more than the software.
AI Supports โ It Does Not Replace
AI can help analyse images, pathology slides and genomic data, but diagnosis must be confirmed by qualified specialists. AI works as a second reader and an organiser of information โ not as a replacement for the pathologist or oncologist.
Eligibility Is Unchanged
Faster workflows do not change trial or treatment eligibility. Advanced therapies and trials still have strict criteria decided by the treating team โ not by software.
Data Governance Varies
Data protection and clinical governance vary by centre and should be asked about directly. Not every AI system is clinically validated for every cancer type, and not every hospital uses the same level of technology.
How CancerFax Helps
Moving from a confusing landscape of AI claims to a structured, realistic plan.
- 1
Report Collection and Case Understanding
Diagnosis, treatment history, current disease status and goals are reviewed to understand what is genuinely relevant.
- 2
Centre and Pathway Matching
Helps identify which hospitals and pathways may suit the case โ matched to tumour type and treatment goal, not hospital reputation alone.
- 3
Second Opinion and Structured Review
Records are shared with appropriate oncology teams for organised feedback, including precision-oncology and trial review where relevant.
- 4
Planning and Cost Clarity
Guidance on likely pathway, required documents, stay duration, logistics and realistic cost ranges before travelling.
- 5
Coordination and Follow-Up
Support with admission, interpreter needs, travel planning and continuity of follow-up after the patient returns home.
Frequently Asked Questions
China's AI-Native Hospitals
Can AI diagnose cancer on its own?
No. AI can help analyse images, pathology slides or clinical data, but the diagnosis must be confirmed by qualified specialists. AI works as a second reader and an organiser of information, not a replacement for the pathologist or oncologist.
Does AI make treatment in China safer or better?
It can help when used responsibly and supervised by experienced doctors, for example by speeding up case review and supporting multidisciplinary discussion. The quality of the medical team and the suitability of the centre for your specific cancer matter more than the technology itself.
Can AI help find a clinical trial for my cancer?
AI-based matching can compare your records against trial eligibility criteria and shorten the search, which is useful in advanced or refractory disease. It does not guarantee enrolment โ final selection depends on the trial team, your clinical condition and the protocol.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Exploring Advanced Cancer Treatment in China?
Share your pathology, imaging and molecular reports. Our clinical team will identify which hospitals and pathways are genuinely relevant for your specific cancer โ not just hospitals with the most technology.
This information is for patient education and navigation support only. All treatment decisions must be made in consultation with a qualified oncologist.